School of Psychology, The University of Sydney, Sydney, Australia.
Pain. 2024 Oct 1;165(10):2257-2273. doi: 10.1097/j.pain.0000000000003251. Epub 2024 May 2.
Nocebo hyperalgesia is a pervasive problem in which the treatment context triggers negative expectations that exacerbate pain. Thus, developing ethical strategies to mitigate nocebo hyperalgesia is crucial. Emerging research suggests that choice has the capacity to reduce nocebo side effects, but choice effects on nocebo hyperalgesia have not been explored. This study investigated the impact of choice on conditioned nocebo hyperalgesia using a well-established electrocutaneous pain paradigm where increases in noxious stimulation were surreptitiously paired with the activation of a sham device. In study 1, healthy volunteers (N = 104) were randomised to choice over (nocebo) treatment administration, nocebo administration without choice, or a natural history control group. Nocebo hyperalgesia was greater for those with choice than no choice, suggesting that choice increased rather than diminished nocebo hyperalgesia. Study 2 tested whether providing positive information about the benefits of choice in coping with pain could counteract heightened nocebo hyperalgesia caused by choice. A different sample of healthy adults (N = 137) were randomised to receive nocebo treatment with choice and positive choice information, choice only, or no choice. The positive choice information failed to attenuate the effect of choice on nocebo hyperalgesia. The current results suggest that, rather than decreasing nocebo hyperalgesia, treatment choice may exacerbate pain outcomes when a painful procedure is repeatedly administered. As such, using choice as a strategy to mitigate nocebo outcomes should be treated with caution.
反安慰剂性痛觉过敏是一个普遍存在的问题,其中治疗环境引发的负面预期会加剧疼痛。因此,制定减轻反安慰剂性痛觉过敏的伦理策略至关重要。新兴研究表明,选择有能力减轻反安慰剂的副作用,但选择对反安慰剂性痛觉过敏的影响尚未得到探索。本研究使用一种成熟的电皮肤痛觉范式,该范式中,增加有害刺激与虚假装置的激活被偷偷地配对,以此来研究选择对条件性反安慰剂性痛觉过敏的影响。在研究 1 中,健康志愿者(N=104)被随机分配到选择(反安慰剂)治疗管理、没有选择的反安慰剂治疗管理或自然史对照组。与没有选择的组相比,有选择的组的反安慰剂性痛觉过敏更严重,这表明选择增加了反安慰剂性痛觉过敏,而不是减轻了它。研究 2 测试了提供关于选择在应对疼痛方面的好处的积极信息是否可以抵消由选择引起的更高的反安慰剂性痛觉过敏。另一组健康成年人(N=137)被随机分配到接受有选择和积极选择信息的反安慰剂治疗、只有选择或没有选择。积极的选择信息未能减轻选择对反安慰剂性痛觉过敏的影响。目前的结果表明,当反复进行痛苦的程序时,治疗选择可能会加剧疼痛结果,而不是减轻反安慰剂性痛觉过敏。因此,应该谨慎地将选择作为减轻反安慰剂结果的策略。